Get started
BrainsWay Ltd.BrainsWay Ltd.BrainsWay Ltd.

BrainsWay Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BWAY chart


Full chart

BWAY upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪173.08 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
99.56
Basic EPS (TTM)
0.09 USD
Net income (FY)
‪−4.20 M‬ USD
Revenue (FY)
‪31.79 M‬ USD
Shares float
‪16.71 M‬
Beta (1Y)
1.18

About BRAINSWAY


Sector
Health Technology
Industry
Medical Specialties
CEO
Hadar Levy
Website
brainsway.com
Headquarters
Jerusalem
Founded
2006
FIGI
BBG00N2K3XL3
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BWAY news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.